Zacks Research downgraded UnitedHealth Group (NYSE: UNH) from a "strong-buy" to a "hold" rating on September 16, 2026. The firm also provided an earnings estimate of $4.06 per share for the fourth quarter of 2027.
The broader analyst consensus for UnitedHealth remains positive, holding a "moderate buy" rating. The average analyst price target is $456.56. This represents a significant upside from the opening price of $375.95 on the day of the report.
The company's last reported quarterly earnings per share were $6.38. Revenue totaled $112.03 billion, exceeding consensus estimates.